Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Quarter Ending	Current	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021	Mar '21 Mar 31, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 30, 2020	Jun '20 Jun 30, 2020	Mar '20 Mar 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	2	4	22	27	32	18	20	46	56	47	55	69	112	206	235	410	109	34	44	45	61
Market Cap Growth	-	-77.92%	11.05%	-42.21%	-43.88%	-62.71%	-63.08%	-32.92%	-49.79%	-76.96%	-76.60%	-83.24%	2.47%	508.19%	436.44%	809.45%	80.16%	-55.98%	91.03%	56.21%	223.98%
Enterprise Value	-13	-10	1	-0	-2	-22	-25	-8	-7	-23	-24	-13	22	109	131	299	-7	13	28	29	41
PE Ratio	-	-0.11	-0.62	-0.73	-0.80	-0.42	-0.47	-1.01	-1.27	-1.16	-1.39	-1.95	-3.58	-7.98	-11.39	-22.24	-6.36	-1.80	-2.26	-1.23	-1.78
PS Ratio	0.72	1.81	12.19	23.14	40.28	26.85	23.50	48.67	37.81	25.30	15.15	15.93	26.00	38.51	61.65	115.69	32.44	13.43	17.62	17.81	25.06
PB Ratio	0.17	0.43	1.43	1.16	1.05	0.48	0.45	0.88	0.92	0.69	0.74	0.86	1.27	2.18	2.29	3.79	0.97	2.16	4.56	4.34	4.25
P/FCF Ratio	-	-0.15	-0.89	-0.93	-0.98	-0.51	-0.49	-1.18	-1.53	-1.38	-1.91	-2.35	-4.22	-8.62	-10.27	-21.09	-6.26	-2.04	-2.89	-2.63	-3.63
P/OCF Ratio	-	-0.15	-0.89	-0.93	-0.98	-0.51	-0.49	-1.18	-1.53	-1.38	-1.91	-2.35	-4.22	-8.62	-10.27	-21.09	-6.26	-2.04	-2.89	-2.63	-3.63
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.04	0.01	0.01
Quick Ratio	2.26	2.26	2.66	4.42	6.59	7.82	9.42	9.90	8.30	9.26	10.50	15.52	16.61	16.73	17.57	19.43	19.93	2.82	1.85	2.19	2.73
Current Ratio	2.39	2.39	2.89	4.66	6.94	8.25	10.37	10.55	8.76	9.81	10.78	16.07	16.99	17.10	18.24	19.76	20.14	3.01	2.00	2.26	2.83
Return on Invested Capital (ROIC)	-385.04%	-235.59%	-165.27%	-137.35%	-117.82%	-98.63%	-89.80%	-73.62%	-59.87%	-53.16%	-44.02%	-35.56%	-27.64%	-20.36%	-17.28%	-15.53%	-117.30%	-193.85%	-336.53%	-228.30%
Buyback Yield / Dilution	-1.60%	-0.41%	-0.82%	-1.13%	-4.13%	-8.76%	-17.29%	-18.39%	-14.60%	-9.76%	-1.42%	-0.68%	-143.43%	-145.42%	-203.95%	-219.73%	-96.58%	-31.20%	-140.07%	-317.71%	-183.37%
Total Shareholder Return	-1.60%	-0.41%	-0.82%	-1.13%	-4.13%	-8.76%	-17.29%	-18.39%	-14.60%	-9.76%	-1.42%	-0.68%	-143.43%	-145.42%	-203.95%	-219.73%	-96.58%	-31.20%	-140.07%	-317.71%	-183.37%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).